Bioray Biotech Co., Ltd (TPEX:7561)
Taiwan · Delayed Price · Currency is TWD 23.15
+0.90 (4.04%)
Mar 26, 2026, 10:20 AM CST
Bioray Biotech Market Cap
Bioray Biotech has a market cap or net worth of 684.9 million as of March 26, 2026. Its market cap has increased by 1.58% in one year.
Market Cap
684.90M
Enterprise Value
581.34M
Revenue
230.06M
Ranking
n/a
PE Ratio
22.57
Stock Price
23.15
Market Cap Chart
Since July 6, 2020, Bioray Biotech's market cap has decreased from 1.94B to 684.90M, a decrease of -64.71%. That is a compound annual growth rate of -16.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 684.90M | 10.77% |
| Dec 31, 2025 | 618.33M | -2.69% |
| Dec 31, 2024 | 635.45M | -31.65% |
| Dec 29, 2023 | 929.63M | 3.17% |
| Dec 30, 2022 | 901.05M | -30.18% |
| Dec 30, 2021 | 1.29B | 56.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tien Liang BioTech | 1.62B |
| GeneFerm Biotechnology | 1.57B |
| InnoPharmax | 1.57B |
| Winston Medical Supply | 1.30B |
| DV Biomed | 1.30B |
| Excelsior Biopharma | 1.23B |
| Anxo Pharmaceutical | 1.08B |
| Original BioMedicals | 1.04B |